Farnesoid X Receptor Expression Is Decreased in Colonic Mucosa of Patients with Primary Sclerosing Cholangitis and Colitis-associated Neoplasia
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Farnesoid X Receptor Expression Is Decreased in Colonic Mucosa of Patients with Primary Sclerosing Cholangitis and Colitis-associated Neoplasia
Authors
Keywords
-
Journal
INFLAMMATORY BOWEL DISEASES
Volume 19, Issue 2, Pages 275-282
Publisher
Oxford University Press (OUP)
Online
2013-01-24
DOI
10.1097/mib.0b013e318286ff2e
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci
- (2012) Trine Folseraas et al. JOURNAL OF HEPATOLOGY
- Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease
- (2011) J. Torres et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Intestinal Inflammation and Cancer
- (2011) Thomas A. Ullman et al. GASTROENTEROLOGY
- Progression of low-grade dysplasia in ulcerative colitis: effect of colonic location
- (2011) Robert Goldstone et al. GASTROINTESTINAL ENDOSCOPY
- Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
- (2011) R. M. Gadaleta et al. GUT
- Dysplasia is more common in the distal than proximal colon in ulcerative colitis surveillance
- (2011) Robert Goldstone et al. INFLAMMATORY BOWEL DISEASES
- Expression of the nuclear bile acid receptor/farnesoid X receptor is reduced in human colon carcinoma compared to nonneoplastic mucosa independent from site and may be associated with adverse prognosis
- (2011) Sigurd Lax et al. INTERNATIONAL JOURNAL OF CANCER
- Early-stage formation of an epigenetic field defect in a mouse colitis model and non-essential roles of T- and B-cells in DNA methylation induction
- (2011) M Katsurano et al. ONCOGENE
- Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease
- (2011) Rian M. Nijmeijer et al. PLoS One
- Bile acids and colon cancer: Solving the puzzle with nuclear receptors
- (2011) Chiara Degirolamo et al. TRENDS IN MOLECULAR MEDICINE
- American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008
- (2009) Douglas K Rex et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-γ-STAT-1 pathway in macrophages
- (2009) Barbara Renga et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis
- (2009) M. M.H. Claessen et al. INFLAMMATORY BOWEL DISEASES
- The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity
- (2009) P. Vavassori et al. JOURNAL OF IMMUNOLOGY
- Nuclear Bile Acid Receptor FXR Protects against Intestinal Tumorigenesis
- (2008) S. Modica et al. CANCER RESEARCH
- Farnesoid X Receptor Deficiency in Mice Leads to Increased Intestinal Epithelial Cell Proliferation and Tumor Development
- (2008) R. R.M. Maran et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started